An Orange County mom, who survived the unimaginable pain of losing her three young children, is in a desperate fight to save ...

A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared ...

A UCL-sponsored clinical trial for patients newly diagnosed with glioblastoma, an aggressive form of brain cancer, has opened ...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint ...

By pairing an mRNA-style vaccine with traditional cancer immunotherapy drugs known as immune checkpoint inhibitors, they were ...

Novocure reported no surprises in its latest quarter, with revenue up 6% for the year and both revenue and loss per share topping Wall Street expectations. The company, which is developing noninvasive ...

Novocure (NASDAQ: NVCR) today reported financial results for the second quarter that ended June 30, 2025. Novocure is a global oncology company working to extend survival in some of the most ...